No Data
Guangzhou Jet Bio-Filtration (688026.SH): The fundraising project "Intelligent Manufacturing Project for Upgrading the Biological Laboratory Consumables Production Line" has been postponed until December 2026.
Glory Securities reported on December 30 that Guangzhou Jet Bio-Filtration (688026.SH) announced that the company held the sixteenth meeting of the fourth Board of Directors and the ninth meeting of the fourth Supervisory Board on December 30, 2024. They reviewed and approved the proposal regarding the extension of some fundraising investment project timelines, agreeing to extend the timeframe for the fundraising project "Upgrading Intelligent Manufacturing of Biological Laboratory Consumables Production Line" to December 2026, and to extend the expected usable status of the fundraising project "New Product R&D Project for Biological Laboratory Consumables" to December 2025.
Guangzhou Jet Bio-Filtration (688026.SH): Plans to use no more than 0.2 billion yuan of idle raised funds to temporarily supplement working capital.
On December 30, Gelonghui reported that Guangzhou Jet Bio-Filtration (688026.SH) announced that it convened the sixteenth meeting of the fourth Board of Directors and the ninth meeting of the fourth Supervisory Board on December 30, 2024, which reviewed and approved the proposal on the temporary use of part of the idle raised funds to supplement working capital. The company agreed to use part of the idle raised funds not exceeding 200 million yuan (including 200 million yuan) for temporary supplementation of working capital, related to the company's main Business production and operation activities. The usage period shall not exceed 12 months from the date of approval by the Board of Directors, within the valid quota.
Jet Biotech: Third quarter report 2024
Third Quarter Report 2024
Guangzhou Jet Bio-Filtration (688026.SH) released its performance for the first three quarters, with a net income of 50.16 million yuan, a year-on-year increase of 259.26%.
guangzhou jet bio-filtration (688026.SH) disclosed the third quarter report for 2024, during the reporting period, the company achieved revenue of 3.9...
guangzhou jet bio-filtration (688026.SH): net income of 50.1568 million yuan in the first three quarters, a year-on-year increase of 259.26%
Guangzhou Jet Bio-filtration (688026.SH) announced on October 23 that the company's revenue for the first three quarters was 0.391 billion yuan, an 18.56% year-on-year increase; net income attributable to shareholders of the listed company was 50.1568 million yuan, a 259.26% year-on-year increase; net income attributable to shareholders of the listed company excluding non-recurring gains and losses was 44.0412 million yuan, a 330.98% year-on-year increase; basic earnings per share was 0.41 yuan.
Guangzhou Jet Bio-Filtration Co., Ltd. (SHSE:688026) Might Not Be As Mispriced As It Looks After Plunging 29%See the daily top gainer.
